Transgender Management Care
Conditions
Keywords
Gynaecology, Gender-affirming hormonal therapy, Breast Cancer, Transgender, Contraception
Brief summary
To date, the transgender population, still poorly characterized, tends to increase. The impact of gender-affirming hormone therapy (GAHT) in this population remains poorly understood, and few data are published on the gynecological repercussions of such therapy. A recent literature review by a French team suggests gynecological follow-up procedures for transgender people.
Detailed description
The hypothesis of this study is that transgender population in France does not have appropriate gynecological care, and the study would like to find out, directly from the people concerned, the current state of gynecological care for transgender people in France. To do this, ths study plan to send out a questionnaire to transgender people (via healthcare networks and also transgender associations) to ask them about their actual gynecological care and their knowledge of recommended gynecological care. The aim is to set up a descriptive, declarative study based on a questionnaire created specifically for this work. This project will use a questionnaire for transwomen people and another one for transmen people. Transgender people will be approached via Trans associations and healthcare networks. An online link to the questionnaire will be sent to trans associations and healthcare networks for distribution to the target population thanks to a flyer.
Interventions
OTHERQuestionnaire
A flyer with QR code leading to the online questionnaire will be sent to trans associations and healthcare networks for distribution to the target population.
Sponsors
University Hospital, Bordeaux
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* French-speaking transgender person (transgender women or transgender men) * age ≥18 years
Exclusion criteria
* age \<18 years
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of people aware of gynaecological recommendations. | 24 months after inclusion day | Percentage of transgender people who know regular gynaecological recommendations in France, thanks to a homemade questionnaire |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Percentage of people aware of cancer risks | 24 months after inclusion day | Overview of organized screening for gynaecological cancers and prostate cancer in the transgender population, thanks to a homemade questionnaire |
| Percentage of people aware of contraception in transgender male population | 24 months after inclusion day | Overview of knowledge about contraception in the transgender male population,thanks to a homemade questionnaire. |
| Percentage of people aware of fertility and the impact of hormone treatments | 24 months after inclusion day | Overview of knowledge about fertility and the impact of hormone treatments in the transgender population, thanks to a homemade questionnaire. |
| Percentage of people aware of gynaecological repercussions of masculinizing hormone treatment in transgender male population | 24 months after inclusion day | Overview of our knowledge of the gynaecological repercussions of masculinizing hormone treatment in the transgender male population, thanks to a homemade questionnaire. |
Countries
France
Outcome results
None listed